BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23616333)

  • 1. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.
    Camarata M; Davies R; Copley S; Blagden S
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumour lysis syndrome in small-cell lung cancer].
    Boshuizen RC; Smit AA; Moons-Pasic A; Bresser P
    Ned Tijdschr Geneeskd; 2016; 160():A9823. PubMed ID: 27334081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: An unusual case and systematic literature review.
    Agarwala R; Batta A; Suryadevera V; Kumar V; Sharma V; Rana SS
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):e29-e31. PubMed ID: 27743982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.
    Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T
    Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour lysis syndrome in haematological malignancies.
    van der Hoven B; Thunnissen PL; Sizoo W
    Neth J Med; 1992 Feb; 40(1-2):31-5. PubMed ID: 1579184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour Lysis Syndrome in children with haematological cancers: Experience at a tertiary care hospital in Karachi.
    Saeed F; Ali MS; Ashraf MS; Vadsaria K; Siddiqui DE
    J Pak Med Assoc; 2018 Nov; 68(11):1625-1630. PubMed ID: 30410139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor lysis syndrome. A life-threatening complication during cytostatic treatment of chemosensitive types of cancer].
    Wibe E; Kvaløy S; Nome O; Abrahamsen AF; Bjørgo S
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2435-7. PubMed ID: 1926084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome after combination chemotherapy for ovarian cancer.
    Bilgrami SF; Fallon BG
    Med Pediatr Oncol; 1993; 21(7):521-4. PubMed ID: 8341221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of ovarian Burkitt lymphoma associated tumor lysis syndrome.
    Cui T; Wang C; He H; Shi G; Hu L
    Eur J Gynaecol Oncol; 2010; 31(2):209-10. PubMed ID: 20527243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare incidence of tumor lysis syndrome in metastatic prostate cancer following treatment with docetaxel.
    Bhardwaj S; Varma S
    J Oncol Pharm Pract; 2018 Mar; 24(2):153-155. PubMed ID: 29284359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations.
    Tambaro FP; Wierda WG
    Lancet Haematol; 2020 Feb; 7(2):e168-e176. PubMed ID: 32004486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous tumour lysis syndrome in small cell lung cancer: a rare phenomenon.
    Dhakal P; Rai MP; Thrasher M; Sharma M
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29898908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study.
    van de Laar R; Zusterzeel PL; Van Gorp T; Buist MR; van Driel WJ; Gaarenstroom KN; Arts HJ; van Huisseling JC; Hermans RH; Pijnenborg JM; Schutter EM; Pelikan HM; Vollebergh JH; Engelen MJ; Inthout J; Kruitwagen RF; Massuger LF
    BMC Cancer; 2014 Jan; 14():22. PubMed ID: 24422892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer.
    Chan JK; Lin SS; McMeekin DS; Berman ML
    J Clin Oncol; 2005 Sep; 23(27):6794-5. PubMed ID: 16170188
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report.
    Baudon C; Duhoux FP; Sinapi I; Canon JL
    J Med Case Rep; 2016 Jun; 10():178. PubMed ID: 27312594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature.
    Taira F; Horimoto Y; Saito M
    Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.
    Drakos P; Bar-Ziv J; Catane R
    Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Near-Future of Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer].
    Nagao S
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):198-202. PubMed ID: 27093731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.